Advertisement

Topics

Aditya Bardia, MBBS, MPH, Advisory Board Member

17:07 EDT 16 May 2019 | GRACE

Massachusetts General Hospital
Member GRACE Advisory Board
Boston
MA
Specialties: 
Breast cancer and drug development/phase I trials, Hematology/Oncology

Massachusetts General Hospital

Hematology/Oncology
55 Fruit Street
Boston, MA 02114-2696


Dr. Bardia is a board-certified medical oncologist interested in developing successful targeted and personalized therapies to improve the outcomes of patients and families afflicted with breast cancer. The accurate identification of target is crucial for success of targeted therapies, and Dr. Bardia is involved in the clinical development of tumor genotyping as well as circulating tumor cells (CTCs) to facilitate accurate diagnosis, therapy selection, and real-time monitoring of breast cancer. In collaboration the CTC center and Haber lab, his research on molecular changes in CTCs in metastatic breast cancer has elucidated the role of epithelial-mesenchymal transition, and provided proof-of-principle that ex-vivo CTC culture and molecular drug testing is feasible in breast cancer. Dr. Bardia is the principal investigator of clinical trials investigating the role of targeted therapy combinations for breast cancer. Dr. Bardia is the recipient of Young Investigator Award from the ASCO Conquer Cancer Foundation.

Original Article: Aditya Bardia, MBBS, MPH, Advisory Board Member

NEXT ARTICLE

More From BioPortfolio on "Aditya Bardia, MBBS, MPH, Advisory Board Member"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...